Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA2 | P47869 | 3/20 | 0.33 |
| ▸ | GABRB2 | P47870 | 3/20 | 0.33 |
| ▸ | GABRP | O00591 | 2/20 | 0.31 |
| ▸ | GABRD | O14764 | 2/20 | 0.31 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.31 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.31 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.31 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.31 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.31 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.31 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.31 |
| ▸ | GABRE | P78334 | 2/20 | 0.31 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.31 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.31 |
| ▸ | GABRG3 | Q99928 | 2/20 | 0.31 |
| ▸ | GABRQ | Q9UN88 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyridate SCHEMBL7579526 | 0.95 | GABRA2 (0.32) | GABRA2GABRB2GABRPGABRDGABRA1 | |
| Pyridate SCHEMBL7579937 | 0.92 | GABRA2 (0.39) | GABRA2GABRB2GABRPGABRDGABRA1 | |
| Pyridate SCHEMBL7586075 | 0.87 | GABRA2 (0.33) | GABRA2GABRB2GABRPGABRDGABRA1 | |
| Pyridate SCHEMBL7579619 | 0.82 | TDP1 (0.49) | — | |
| Pyridate SCHEMBL7586336 | 0.81 | MEN1 (0.40) | — | |
| Pyridate SCHEMBL18115236 | 0.81 | ADORA3 (0.33) | — | |
| Fomesafen SCHEMBL7587165 | 0.80 | TDP1 (0.42) | — | |
| Glyphosate SCHEMBL7575525 | 0.79 | GABRA2 (0.40) | GABRA2GABRB2GABRPGABRDGABRA1 | |
| Pyridate SCHEMBL7585041 | 0.78 | TDP1 (0.42) | — | |
| Lactofen SCHEMBL7583309 | 0.78 | TDP1 (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020004457-A1 | Herbicidal composition | SYNGENTA PARTICIPATIONS AG (CH) | 2002-01-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020004457-A1 | Herbicidal composition | PPOX, ALAD, DDT | GABRA2 2504/4885GABRB2 1687/4885GABRP 1909/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.